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Summary
Mesoderm and endoderm in C. elegans arise from sis-
ter cells called MS and E, respectively. The identities
of both of these mesendodermal progenitors are con-
trolled by MED-1 and -2, members of the GATA factor
family. In the E lineage, these factors activate a se-
quential cascade of GATA factors, beginning with
their immediate targets, the endoderm-specifying end
genes. We report that MED-1 binds invariant nonca-
nonical sites in the end genes, revealing that the
MEDs are atypical members of the GATA factor family
that do not recognize GATA sequences. By searching
the genome for clusters of these MED sites, we have
identified 19 candidate MED targets. Based on their
expression patterns, these define three distinct classes
of MED-regulated genes: MS-specific, E-specific, and
E plus MS-specific. Some MED targets encode tran-
scription factors related to those that regulate mesen-
doderm development in other phyla, supporting the
existence of an ancient metazoan mesendoderm gene
regulatory network.
Introduction
Cell fates are differentially apportioned during animal
development by the deployment of specific gene regu-
latory networks involving cross-regulating transcription
factors and their target genes (Bolouri and Davidson,
2003; Davidson et al., 2003). In many cases, two dis-
tinct networks are activated in the daughters of a single
cell. While mechanisms that control such develop-
mentally asymmetric cell divisions have been charac-
terized, there is no example in which unique gene regu-
latory networks activated in each of the daughters is
comprehensively known.
The pathway that specifies endoderm development
in C. elegans is among the best understood transcrip-
tional regulatory network in this rapidly developing ani-
mal (Maduro and Rothman, 2002). This innermost germ
layer arises from a single cell, E, that is born by an
asymmetric division of the mesendoderm precursor,
EMS, the ventral-most cell in the four-cell embryo. The
sister of E, the MS cell, engenders most of the me-
soderm. Remarkably, despite their radically different
fates, E and MS are initially specified by the same tran-*Correspondence: rothman@lifesci.ucsb.edu
2 These authors contributed equally to this work.
3 Present address: Department of Biology, University of California,
Riverside, Riverside, California 92521.scriptional cascade: the maternal bZIP/homeodomain
protein SKN-1 directly activates transcription of the
med-1 and -2 genes, which encode redundant mem-
bers of the GATA factor family (Figure 1) (Bowerman et
al., 1993; Maduro et al., 2001). The differential action of
MED-1,2 is regulated by the Tcf/Lef-1-like factor POP-1
(Lin et al., 1998; Lin et al., 1995; Maduro et al., 2002). In
MS, POP-1 represses the endoderm-specifying end-1,3
genes (Maduro and Rothman, 2002; Zhu et al., 1997),
allowing MED-1,2 to activate expression of MS-specific
target genes. Convergent Wnt, MAP kinase, and src
signaling pathways activated in the E lineage as a result
of a polarizing inductive interaction in EMS convert
POP-1 from a repressor to an activator of the endo-
derm-specifying end-1,3 genes, thereby allowing both
MED-1,2 and POP-1 to promote endoderm develop-
ment in the E lineage (Rocheleau et al., 1997; Thorpe et
al., 1997; Rocheleau et al., 1999; Shin et al., 1999; Bei
et al., 2002; Maduro et al., 2001; Maduro et al., 2002).
Results and Discussion
MED-1 binds in vivo to the end-1,3 promoters present
on extrachromosomal transgenes in both the E and MS
cells (Maduro et al., 2002), raising the possibility that
MS-specific target genes may bind MED-1 in both E
and MS through the same recognition sequence as the
E-specific end-1 and end-3 genes. To investigate this
possibility and to initiate analysis of the gene regulatory
networks that direct E and MS development, we sought
to define the MED-1 sites in end-1 and end-3. We per-
formed electrophoretic mobility shift assays with full-
length MED-1 protein and DNA fragments that accu-
rately drive reporter expression in the early E lineage
(Figure 2; data not shown). At low concentrations of
MED-1, we detected a single MED-1::DNA complex;
additional bands appeared as the concentration was
increased, consistent with the formation of higher order
complexes (Figure 2C). We conclude that MED-1 can
bind to the end-1 and end-3 promoters in vitro, validat-
ing our in vivo results (Maduro et al., 2002).
To identify the MED-1 binding sites in end-1 and
end-3, we performed DNase I footprinting analysis.
These experiments revealed two MED-1 binding sites
in end-1 and four in end-3 (Figure 2A). Somewhat unex-
pectedly, none of these six sites contain the rather flexi-
ble HGATAR core sequence typical of GATA factors
(Lowry and Atchley, 2000), but instead define the more
specific consensus 5#-RRRAGTATAC-3#, henceforth de-
noted a MED site, which contains an invariant, partially
palindromic, core sequence (underlined). To investigate
whether the MED sites were the only sites of interac-
tion, we constructed versions of the end-1 promoter
fragment in which one or both MED sites were mutated.
While mutation of either site alone did not abrogate the
gel shift, loss of both eliminated it entirely, indicating
that a single MED site is sufficient for binding (Figure
2C). In contrast, we found that both MED sites were
required for in vivo expression from the same promoter
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428Figure 1. Origin of the MS and E Blastomeres and Alignment of the GATA-Like Zinc Finger of MED-1
(A) The C. elegans mesendodermal precursor (EMS), shown at the four-cell stage, generates the MS (mesoderm) and E (endoderm) progeni-
tors, which are specified by the med-1,2 genes. Although MS and E are sister cells, they give rise to completely different lineage patterns
(Sulston et al., 1983). The E fate is specified by the direct activation of end-1,3 by MED-1,2 (Maduro et al., 2001; Maduro and Rothman, 2002).
(B) Alignment of the MED-1 zinc finger and basic domain with those of other GATA factors. Amino acids in black boxes represent identities
with MED-1, while gray boxes indicate conservative changes defined by BLOSUM62 (Henikoff and Henikoff, 1992). Residues marked with an
asterisk (*) are conserved in all GATA factors shown except for MED-1, possibly accounting for its unusual binding specificity. Ce-MED-1, Ce-
END-1, Ce-ELT-1 are from C. elegans (Accession numbers CAA92204, T37244, and CAA92494, respectively); cGATA1 is from chicken
(G. gallus, A32993); mGATA1 is from mouse (M. musculus; P17679); The fungal An-AreA is from A. niger (X99940). “Cf” indicates the carboxyl
finger of a two-fingered protein.fragment (Figure 2D). While the end-1 and end-3 pro- G
Omoter fragments used for the binding studies contain a
consensus GATA site, removal of both MED sites (but
lwith the GATA site intact) eliminated MED-1 binding to
the end-1 fragment. Moreover, neither WGATAR site in g
dend-1 or end-3 showed any evidence of DNase I pro-
tection by MED-1 (data not shown). The finding that c
(MED-1 does not recognize a canonical binding site was
not predicted from its primary amino acid sequence, as q
tits single C4 zinc finger most strongly resembles those
of the GATA class of transcription factors (Lowry and o
aAtchley, 2000; Maduro et al., 2001). However, its finger
is different at some of the key residues known to make c
tbase-specific contacts within the GATA core, and the
finger overall is the most divergent of the C. elegans oATA factors (Figure 1B) (Lowry and Atchley, 2000;
michinski et al., 1993; Starich et al., 1998).
The rigid consensus and apparent requirement of at
east two MED-1 sites for in vivo expression of end-1 sug-
ested that it might be possible to identify new mesen-
oderm genes by searching for regulatory regions that
ontain clusters of MED sites. Using WormEnhancer
http://www.wormenhancer.org), we identified 12 se-
uences in the C. elegans genome containing at least
wo nonoverlapping MED sites within 100 bp of each
ther. Based on preliminary characterization of genes
ssociated with these clusters, we widened the search
onsensus to 5#-RAGTATAC-3# and identified 50 clus-
ers. We narrowed the list to 21 candidate genes based
n the proximity of the clusters to a nearby coding re-
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429Figure 2. MED-1 Binding Sites and Expres-
sion of Putative Target Genes
(A) DNase I footprint analysis of end-1 and
end-3 promoter fragments. The fragments
used contained either 236 bp upstream of
the end-1 start codon or 284 bp upstream of
the end-3 start codon; in both cases, these
fragments are sufficient to drive faithful
E-specific expression of a reporter con-
struct. Two sites (i-ii) are protected in end-1,
while four sites (iii-vi) are protected in end-3.
(B) Location of MED-1 sites in end-1 and
end-3, shown as distance upstream of the
start codon, and alignment of DNase I-pro-
tected sites to form a consensus with an in-
variant core sequence (gray shading). The
MED-1 binding site does not conform to the
canonical GATA binding site.
(C) Gel shift with wild-type and point-
mutated MED sites. Substitution of each
MED-1 site in the end-1 promoter (shown as
“X” in the diagrams) permits MED-1 binding
at the other site, but mutation of both sites
abolishes the MED-1 shift. Site (i) was mu-
tated from 5#-aagtatacc-3# to 5#-aactagtcc-
3# and site (ii) was mutated from 5#-aagtat
acc-3# to 5#-aagtctaga-3#.
(D) Fluorescence micrographs of w100-cell
embryos showing expression of minimal
end-1 promoter::GFP fusions. Mutation of
either MED-1 site abolishes expression.
(E) Reporter expression of putative MED-1
target genes falls into three classes. The
Class A genes sox-1 and hlh-28 are ex-
pressed in both the MS and E lineages, the genes hlh-25 and tbx-35 are expressed in the MS lineage (Class B), and wee-1.1 and T07D1.2
are expressed in the early E lineage (Class C). In embryo images, anterior is to the left, and dorsal is up; the eggshell is indicated with a
dotted line.gion (i.e., within 2 kb upstream, or within a first intron;
Table 1). The majority of such clusters (15/21) contain
two MED sites, 5/21 contain three sites, and a single transcription factors. Two genes (F49B2.4 and F35H8.7/
Table 1. Putative MED-1 Target Genes Identified by MED Binding Site Clusters
Number Nearest Gene
Cluster of Sites (Distance to ATG) Gene Family Reporter Expressiona Classb
1 3 C32E12.5 (1st intron), sox-1 Sry-like HMG box (Sox) early MS and E lineages A
2 2 ZK849.2 (300bp) PDZ domain none detected
3 2 F49B2.4 (1.7kbp) cyclin-like F-box n.d.
4 3 ZK177.10 (150bp), tbx-35 T-box early MS lineage B
5 2 C17C3.7 (1st intron), hlh-25 bHLH early MS lineage B
6 2 C17C3.10 (1st intron), hlh-27 bHLH early MS lineage, others B
7 2 F35H8.7 (250bp), wee-1.1 wee1 kinase early E lineage, others C
8 2 K10F12.6 (1.4kbp) uncharacterized n.d.
9 2 F31E3.2 (intron), ceh-20 homeobox none detected
10 3 B0303.8 (200bp) uncharacterized none detected
11 2 Y66A7A.8 (1st intron), tbx-33 T-box n.d.
12 2 F13E9.6 (150bp) uncharacterized n.d.
13 2 K02H11.7 (50bp), str-243 chemoreceptor n.d.
14 2 F58G4.4 (200bp) LAG-2-like early E lineage C
15 2 T11A5.5 (100bp) uncharacterized early E lineage C
16 2 F58E10.2 (220bp), end-1 GATA factor early E lineage C
17 4 F58E10.5 (250bp), end-3 GATA factor early E lineage C
18 2 T07D1.2 (250bp) uncharacterized early E lineage C
19 2 B0563.1(600bp) SRP-RNP n.d.
20 3 F31A3.4 (200bp), hlh-29 bHLH early MS, E lineage A
21 3 F31A3.2 (200bp), hlh-28 bHLH early MS, E lineage A
n.d., not determined. All genes are defined by the gene models described in Wormbase (http://www.wormbase.org) release WS110.
a “E” or “MS” lineage indicates that expression was visible in the early lineage of E or MS in embryos younger than the E8/MS16 stage.
b Class A, expression in both MS and E lineages; B, MS lineage only; C, E lineage only.gene (end-3) contains four sites. Approximately half (10)
of the putative MED target genes are predicted to be
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430wee-1.1) are predicted to have roles in the cell cycle. p
rwee-1.1 has been previously shown to be expressed in
the E cell and repressed in MS in a POP-1-dependent f
tmanner (Wilson et al., 1999), suggesting that wee-1.1,
and at least some of the other candidate genes, are c
nbona fide MED-1 targets. Finally, we note that six of the
MED clusters appear to represent recently duplicated e
tgenes (hlh-25/hlh-27, end-1/3 and hlh-28/29), suggest-
ing that genetic redundancy by gene duplication is a p
sfeature of both the mesoderm and endoderm networks
in C. elegans (Maduro and Rothman, 2002). a
sWe constructed GFP reporters for several of the pu-
tative MED-1 target genes to assess their expression p
hpatterns. Of 15 genes tested, 12 were expressed in the
early EMS descendants, suggesting that they are di- i
crectly activated by the MEDs. These genes fell into
three classes (Table 1; Figure 2E). Class A, represented t
gby three genes, sox-1, hlh-28, and hlh-29, are ex-
pressed in all cells of the early MS and E lineages; thus, o
tthese genes are apparently activated wherever MED-
1,2 are expressed. Class B includes three putative tran- m
iscription factors, tbx-35, hlh-25, and hlh-27, expressed
exclusively in the early MS lineage. The six Class C p
egenes, end-1, end-3, wee-1.1, a gene encoding a
Notch-like receptor (F58G4.4), and two uncharacterized p
cgenes, T11A5.5 and T07D1.2, show E lineage-specific
expression. m
aTo assess whether expression of these genes de-
pends on MED activity, we examined the expression of 1
sthe MS-specific tbx-35 and hlh-25 genes in greater de-
tail. Expression of both genes was found to be altered m
sin genetic backgrounds in which MED-1 is absent or
ectopically expressed (Figures 3B-3D): in all cases, ex- c
spression of these genes coincided with that of med-1
and specification of an MS fate. Finally, we used the 3
o“nuclear spot assay” (Fukushige et al., 1999) to test for
interaction of GFP::MED-1 with the tbx-35 and hlh-25 t
ppromoters in vivo. When an end-1::lacZ reporter is in-
troduced into a med-1::GFP::MED-1 strain, the GFP be- c
acomes localized to discrete spots within nuclei of EMS
descendants, representing the intranuclear location of n
ithe extrachromosomal transgene (Maduro et al., 2002).
When a tbx-35::lacZ or hlh-25::lacZ reporter is used,
asimilar spots form, consistent with in vivo interaction of
GFP::MED-1 with their promoters in both the MS and E l
mlineages (Figures 3E-F; data not shown). Collectively,
these findings demonstrate that tbx-35 and hlh-25 are c
abona fide MED-1 target genes. As these genes are acti-
vated only in the MS lineage, a mechanism must exist i
mto prevent their MED-dependent activation in the E lin-
eage (Figure 3G), analogous to POP-1 repression of a
mend-1,3 in the MS lineage (Maduro et al., 2002).
The failure of MS to be specified in skn-1(−) or med-1, t
t2(−) mutant embryos results in its transformation into a
C-like mesectodermal precursor (Bowerman et al., s
t1992; Maduro et al., 2001). We performed RNAi experi-
ments in an effort to examine the functional require- n
Wment for the MS lineage-specific tbx-35, hlh-25/27, or
hlh-28/29 genes in specification of the early MS lin- i
ieage. We were unable to observe any phenotype con-
sistent with failure of MS specification in tbx-35(RNAi), b
ohlh-25(RNAi), hlh-25(RNAi); hlh-28(RNAi) or tbx-
35(RNAi); hlh-25(RNAi) using the potent delivery method t
gof gonadal dsRNA injection (Fire et al., 1998). One inter-retation for this finding is that these genes function
edundantly with other regulators. Evidence for the
unction of genetically redundant genes may be ob-
ained by assessing whether their expression is suffi-
ient to transform the fates of cells in which they are
ormally not expressed. For example, although appar-
nt null mutations of end-1 show no phenotype owing
o genetic redundancy with end-3 (M.M. and J.H.R., un-
ublished data), we previously found that overexpres-
ion of the END-1 GATA factor is sufficient to specify
n endodermal fate in all early non-endodermal
omatic cells (Zhu et al., 1998). We found that overex-
ression of hlh-25 driven by a heat-shock promoter::
lh-25 fusion transgene during embryogenesis results
n arrested embryos, consistent with possible respecifi-
ation of cell fates. To test whether ectopic hlh-25 ac-
ivity is sufficient to specify mesoderm tissues normally
enerated in the MS lineage, we examined the effect
f broadly expressing hs-hlh-25 in mutant backgrounds
hat greatly reduce the amount of pharynx or body wall
uscle. In skn-1 mutant embryos, no pharynx tissue
s made, and ectopic C lineage-type muscle is instead
roduced by the descendants of MS and E (Bowerman
t al., 1992). The maternal Caudal-like homeodomain
rotein PAL-1 is required for specification of C fate, in-
luding C-derived muscle; thus, skn-1; pal-1 double
utant embryos produce very few muscle cells (Hunter
nd Kenyon, 1996). We compared heat-shocked skn-
(RNAi) and skn-1(RNAi); hs-hlh-25 embryos and ob-
erved no difference in the amount of pharynx muscle
ade (data not shown). In contrast, a fraction of heat-
hocked skn-1(RNAi); pal-1(RNAi); hs-hlh-25 embryos
ontained extra muscle cells compared to heat-
hocked skn-1(RNAi); pal-1(RNAi) embryos (Figures
H–3J). Although this effect was not as dramatic as that
bserved with overexpressed end-1 (Zhu et al., 1998),
hese data suggest that hlh-25 is sufficient to direct a
rogram of body muscle development in at least some
ells. Elucidating the requirements for hlh-25, tbx-35,
nd other regulators for MS fate will likely require elimi-
ating their functions in many combinations and isolat-
ng chromosomal mutations in them.
It is notable that we were able to identify a set of
pparent MED-1 targets reliably by searching for regu-
atory regions containing MED site clusters. Of the
any possible sites that a transcription factor can re-
ognize in the genome, typically only a small fraction
re actually bound, or function, in vivo, presumably ow-
ng to differences in chromosomal context or require-
ents for coregulators that bind cooperatively (Iyer et
l., 2001; Ren et al., 2000; Wyrick and Young, 2002). We
ight therefore have expected that only a small frac-
ion, rather than 80%, of the putative MED-1 targets
ested would have shown EMS lineage-specific expres-
ion. Genome-wide expression analysis has been used
o study genes that are coregulated under differing ge-
etic, developmental, or environmental conditions (e.g.,
yrick and Young, 2002). This strategy was used to
dentify candidate target genes of the C. elegans organ
dentity gene PHA-4, an approach that was successful
ecause PHA-4 is required continuously for expression
f pharynx genes (Gaudet and Mango, 2002). To iden-
ify genes regulated by a particular transcription factor,
enome-wide location analysis can be used to identify
Targets of the Atypical MED-1 GATA Factor
431Figure 3. Evidence That MED-1 Regulates
Putative Targets In Vivo and That These May
Function in Specification of MS-Derived
Fates
(A–D) hlh-25::GFP responds appropriately to
perturbations in med-1 activity. (A) Wild-type
hlh-25::GFP in MS daughters. (B) skn-1(RNAi)
embryos, which do not express med-1,2 and
fail to specify MS (Bowerman et al., 1992;
Maduro et al., 2001), also fail to express hlh-
25. (C) In pie-1 mutants, the C blastomere
usually adopts the fate of MS (Mello et al.,
1992), and hlh-25 is ectopically expressed in
the C daughters. (D) Ectopic MED-1 pro-
duced by a heat-shock construct is sufficient
to drive widespread hlh-25 expression.
(E–G) Nuclear spot assay validates MED-1
interaction with tbx-35 in living embryos.
GFP::MED-1 forms subnuclear spots in the
presence of a tbx-35::lacZ transgene array in
the nuclei of MS and E nuclei (E) and their
daughters (F), even though tbx-35 is ex-
pressed only in the MS lineage. The mecha-
nism that prevents activation of tbx-35 in the
E cell is unknown (G).
(H–J) Overexpression of hlh-25 by heat
shock (hs) directs muscle cell specification.
(H) Mutants lacking skn-1 and pal-1 activities
make very little muscle, as shown by the
muscle marker hlh-1::GFP (Hunter and Ken-
yon, 1996; Krause et al., 1990). (I) Overex-
pression of hlh-25 from a heat shock con-
struct early in development restores muscle
differentiation to a small proportion of these
embryos. (J) Distribution of embryos display-
ing muscle cells following heat shock of con-
trol skn-1(RNAi); pal-1(RNAi) embryos and
those carrying an hs-hlh-25 transgene. The
increase in numbers of muscle cells in hs-
hlh-25 animals is significant (p<0.001).
(K) Model of transcriptional regulatory hierar-
chies in C. elegans mesendoderm specifi-
cation. Maternal SKN-1 directly activates
med-1 and -2 (Maduro et al., 2001), which in turn directly control expression of target genes specific for mesoderm, endoderm, or mesendo-
derm. The Wnt/MAPK pathway input dictates specificity of target gene activation for those targets whose expression is restricted to MS or E.the promoter regions bound by the regulator in vivo
(Wyrick and Young, 2002). Our successful in silico iden-
tification of genome-wide MED-1 targets is likely a re-
sult of the imposed constraints of the search (i.e., the
close occurrence of >2 MED sites in proximity to the
start of a coding region) combined with the rigid se-
quence requirements of the MED consensus binding
site. Further, MED-1,2 function during a very short time
in early embryonic development, apparently by initiat-
ing, but not maintaining, the expression of downstream
targets (Maduro and Rothman, 2002).
It is possible that the genome is generally receptive
to binding and activation through pairs of MED sites
during early phases of development and, therefore, that
there is strong selection against these sequences near
genes whose mesendodermal expression would be de-
trimental. This would predict that expression of MED-1
is alone sufficient to activate a mesendodermal pro-
gram of development; we have observed that ectopic
expression of med-1, which occurs in certain mutant
backgrounds, is necessary and sufficient to specify ec-
topic mesendoderm fates (Maduro et al., 2001). There
is precedent for GATA factors possessing the ability toenhance the accessibility of DNA to the transcription
machinery, in addition to functioning as activators: the
fungal GATA factor AreA has been shown to be involved
in chromatin remodeling (Muro-Pastor et al., 1999), and
vertebrate GATA4 can bind to its site in compacted
chromatin and establish an open chromatin state (Cir-
illo et al., 2002). Together, these observations suggest
that the primary determinant for MED-1,2 activation of
a gene may be the presence of MED binding sites in
its promoter.
The apparent participation of sox-1, tbx-35, and hlh-
25 in the pathway for EMS development raises the pos-
sibility that we have identified elements of an ancient
conserved mesendoderm gene regulatory network (e.g.,
Rodaway and Patient, 2001) that is used by both pro-
tostomes (e.g., C. elegans) and deuterostomes (e.g.,
vertebrates and echinoderms). SOX-1 belongs to the
Group C Sox genes (Bowles et al., 2000; Wegner, 1999),
of which murine Sox-4 is a member (Schilham et al.,
1996). Mice lacking Sox-4 display defects in the devel-
opment of cardiac tissue and blood, two mesodermal
tissues (Schilham et al., 1997; Schilham et al., 1996).
TBX-35 is a member of the T-box family, defined by the
Developmental Cell
432Pvertebrate Brachyury gene, which is required for meso-
Tderm formation in a variety of animals (Cunliffe and
6Smith, 1992; Herrmann and Kispert, 1994; Stennard et
i
al., 1996; Willison, 1990). HLH-25 is a member of the O
bHLH family, of which MyoD, myogenin, Myf5, and g
tMRF4 function in a cascade controlling muscle devel-
topment (Molkentin and Olson, 1996). While hlh-1 is the
fproposed MyoD homolog (Krause et al., 1990), hlh-25,
lwhich is expressed upstream of hlh-1, may be analo-
2
gous to another member of the vertebrate cascade that 2
functions upstream of MyoD. The endomesoderm gene N
Dregulatory network in the sea urchin contains SoxB1 (a
Tmember of a different class of Sox gene), a Brachyury
(homolog, and the GATA factors GataE and GataC (Da-
tvidson et al., 2002), although the relationships between
(
some of these regulators appears to diverge from what
we have observed here. It is clear that further decon- G
struction of the mesendoderm gene regulatory network P
3in nematodes and other animals is required to assess
fthe degree to which the architecture of these networks
−has been maintained over >600 million years.
f
The genes we have identified define three classes of m
responsiveness to the MED transcription factors posi- l
tioning them centrally in a hierarchical network that ini- b
atiates mesendoderm development in C. elegans (Figure
m3K). Repression of E-specific genes by POP-1 is insuffi-
fcient to explain the differential action of the MEDs on
b
the two nonequivalent daughter cells of EMS, as re- a
vealed by the existence of class B target (MS-specific) l
genes. It will be of particular interest to assess how the a
dMED transcription factors (which are nearly identical in
sequence and expression) differentially activate E-spe-
cific and MS-specific gene expression. For example,
A
does POP-1 repress class B genes in the E lineage or
activate them in the MS lineage? The identification of W
these three classes of MED-regulated genes will make o
tit possible to dissect the regulatory code that estab-
blishes differential activation of gene regulatory net-
Mworks in daughter cells produced by asymmetric cell
D
divisions.
R
RExperimental Procedures
A
PCloning and Strains
Reporter GFP constructs were generated by using PCR to amplify
Rfrom a region several hundred base pairs upstream of the MED-1
sites to a similar distance downstream of the predicted ATG. Prod-
Bucts were cloned into an NLS::GFP and/or NLS::lacZ expression
Kvector (from A. Fire). Oligonucleotide sequences and cloning de-
atails are available on request. Transgenic unc-119(ed4) animals
twere generated by coinjection of a reporter fusion plasmid and an
unc-119(+) plasmid. Spot assay strains were generated by intro- B
ducing lacZ reporter arrays into a GFP:MED-1 strain as described c
in Maduro et al. (2002). dsRNA was synthesized from T7-tagged n
PCR products and injected into the gonad of hermaphrodites as B
described (Maduro et al., 2001). Strain ccIs7963 V (hlh-1::GFP) was n
a gift from J. Hsieh and A. Fire. m
For the heat shock experiments, the predicted hlh-25 coding re-
B
gion was cloned into the heat shock vectors pPD49.78 and
T
pPD49.83 (gifts from A. Fire). Control animals carrying an hlh-1 re-
e
porter (ccIs7963) and an hs-hlh-25 transgene marked by rescue of
Bunc-119 were injected with skn-1 and pal-1 dsRNA and allowed to
trecover for 18 hr at 20°C. Gravid hermaphrodites were heat
sshocked for 30 min at 33°C, allowed to lay eggs for 5 hr at 20°C,
and the eggs scored for the number of hlh-1::GFP-expressing nu- C
Kclei after a further 10 hr.urification of Recombinant MED-1
he MED-1 coding region was cloned as a PCR product into the
× His fusion plasmid pET15b. The fusion protein was expressed
n E. coli codon plus RIL cells (Novagen) by growth at 37°C to an
D of 0.3 followed by induction with 0.1 mM of isopropyl-β-D-thio-
alactopyranoside overnight at 30°C. Cells were pelleted by cen-
rifugation and resuspended in BugBuster HT (Novagen) according
o the manufacturer’s instructions. The recombinant protein was
ound to be completely insoluble and was therefore purified as fol-
ows: inclusion bodies were washed 2× with 10% Bugbuster and
× with water, then denatured in 8 M urea, 50 mM Tris (pH 7.5), and
5mM DTT on ice. Protein was renatured in a 10× volume of 1M
DSB-256 (Novagen), 50 mM Tris (pH 7.5), 500 mM NaCl, 0.5 mM
TT, 0.5mM zinc sulfate, and 10% glycerol (Vuillard et al., 1998).
he refolded extract was then purified on a Ni2+ affinity column
Amersham). The His tag was removed by thrombin cleavage and
he protein stored at −20°C in 50% glycerol, 1 mM DTT, 10 mM Tris
pH 7.5).
el Shift and DNaseI Footprinting Experiments
robes for EMSA were gel-purified PCR products generated with a
2P end-labeled primer and an unlabeled primer. The regions ampli-
ied were from −233 bp to +27 bp relative to the end-1 ATG, and
302 bp to −9 bp relative to the end-3 ATG. Gel shift and DNase-I
ootprinting reactions were performed at 23°C in 10% glycerol, 10
M Tris (pH 7.5), 50 mM KCl, 0.5 mM DTT and 25 pM 32P-end-
abeled probe with 12, 24, 48 nM MED-1. Following a 20 min incu-
ation, protein-DNA complexes were separated by EMSA on a 9%
crylamide gel in 0.5% TGE buffer (12.5 mM Tris, 95 mM glycine, 5
M EDTA [pH 8.3]) containing 2.5% glycerol at 8 V/cm at 22°C. For
ootprinting, the complexes were treated with 2 U of DNaseI (Am-
ion) for 1 min and then organically extracted with phenol. The
queous phase was desalted using a P6 column (BioRad), lyophi-
ized to 2 L, resuspended in formamide gel loading buffer, and
nalyzed on a denaturing 7% sequencing gel according to stan-
ard protocols.
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